As outlined in the Introduction section, the goal of the present study was to determine whether the modulation of 5-HT system through the selective blockade of 5-HT2 receptors (sarpogrelate) could rescue the damaged cardiovascular parameters in T1D. The gene discussed is HTR2A; the disease is type 1 diabetes mellitus.